Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»283710.69541/NRIPH.2024.03.010Научная статьяCOVID-19 and chronic non-infectious diseases in the patients with fatal outcome according to the Federal Register in Tomsk regionNaydenovaNadezhda E.nadiet@mail.ruhttps://orcid.org/0000-0002-4085-388XIlyinskikhEkaterina N.infsibgmu@list.ruhttps://orcid.org/0000-0001-7646-6905NagaytsevAlexander V.nagaicev.av@mail.ruhttps://orcid.org/0000-0002-6593-6585StasyukNatalya A.stasuk.na@ssmu.ruhttps://orcid.org/0000-0001-6336-1522AmonotidiAnastasia V.amonotidi.n@gmail.comhttps://orcid.org/0009-0008-8651-8287Siberian State Medical UniversitySiberian State Medical University,Tomsk Regional Clinical Hospital011020243667127052025Copyright © 2025,2025<p>The results obtained are based on the data from Federal Register of Persons with the Novel Coronavirus Infection COVID-19. The study included the information from 160 deceased patients hospitalized from November 2020 to January 2021 in the repurposed therapeutic departments of the respiratory hospital of Tomsk Regional Clinical Hospital. Almost half of the patients with fatal outcome from COVID-19 were multimorbid (46.3%). The most common combination of CSD and respiratory diseases was found in 33.1% of cases. A negative correlation was revealed between the length of stay of deceased patients in the hospital and the age of the patients (rs = 0.172; p 0.05).</p>Federal RegisterCOVID-19fatal outcomechronic non-communicable diseasescirculatory system diseasesendocrine system diseasesфедеральный регистрCOVID-19летальный исходхронические неинфекционные заболеванияболезни системы кровообращенияболезни эндокринной системы[Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Polyakov D.S., Belenkov Yu.N., Konradi A.O., et al. International register «Dynamics analysis of comorbidities in SARSCoV-2 survivors» (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2021; 26(4):4470 (In Russian). DOI:10.15829/1560-4071-2021-4470][Mehra M.R., Desai S.S., Kuy S.R., Henry T.D., Patel A.N. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. 2020;382(26):2582. DOI: 10.1056/NEJMoa2007621][Kluge H.H.P., Wickramasinghe K., Rippin H.L., Mendes R., Peters D.H., Kontsevaya A. et al. Prevention and control of non-communicable diseases in the COVID-19 response. Lancet. 2020;395(10238):1678?80. DOI: 10.1016/S0140-6736(20)31067—9][Drapkina O.M., Karpov O.E., Loukianov M.M., Martsevich S.Yu., Pulin A.A., Kutishenko N.P. et al. Experience of creating and the first results of the prospective hospital registry of patients with suspected or confirmed coronavirus infection (COVID-19) and community-acquired pneumonia (TARGET-VIP). Preventive medicine. [Profilakticheskaya meditsina]. 2020;23(8):6?13 (in Russian). DOI: 10.17116/profmed2020230816][Konradi A.O., Villevalde S.V., Duplyakov D.V., Kozlenok A.V., Melnik O.V., Mikhailov E.N., et al. An open-label multicenter observational study (registry) of patients recovered from coronavirus disease 2019 (COVID-19) with involvement of the cardiovascular system or with baseline severe cardiovascular diseases: rationale, design, and implications for clinical practice. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2021;26(1):4287. (in Russian). DOI:10.15829/1560-4071-2021-4287.][Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Y.N., Konradi A.O., Lopatin Y.M., et al. International register «Dynamics analysis of comorbidities in SARS-CoV-2 survivors» (AKTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal]. 2020;25(11):4165 (in Russian). DOI: 10.15829/1560-4071-2020-4165][Naydenova N.E., Ilyinskikh E.N., Ostrikova O.I., Shilovskaya K.Yu., Komogortseva K.A., Chenusha D.S., et al. COVID19 and chronic non-communicable diseases: analysis of data from the Federal Register in the Tomsk region. Bulletin of Semashko National Research Institute of Public Health. [Byulleten' Natsional'nogo nauchno-issledovatel'skogo instituta obshchestvennogo zdorov'ya imeni N.A.Semashko]. 2023;(3):48—55 (in Russian). DOI: 10.25742/NRIPH.2023.03.008][Li B, Yang J., Zhao F., Zhi L., Wang X., Liu L. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531?8. DOI: 10.1007/s00392-020-01626-9][Boytsov S.A., Martsevich S.Y., Kutishenko N.P., Drozdova L.Yu., Lukyanov M.M., Zagrebelnyi A.V., et al. Registers in cardiology: their principles, rules and real-word potential.[Cardiovascular Therapy and Prevention. [Kardiovaskulyarnaya terapiya i profilaktika]. 2013;12(1):4?9 (in Russian).][Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054?62. DOI: 10.1016/S0140-6736(20)30566—3][Molochkov A.V., Karateev D.E., Ogneva E.Yu., Zulkarnaev A.B., Luchikhina E.L., Makarova I.V. et al. Comorbid diseases and predicting the outcome of COVID-19: results of observation of 13,585 patients who were hospitalized in hospitals in the Moscow region. Almanac of Clinical Medicine. [Al'manakh klinicheskoy meditsiny]. 2020;48(S1):S1—10 (in Russian). DOI: 10.18786/2072-0505-2020-48-040][Svarovskaya A.V., Shabelsky A.O., Levshin A.V. Charlson comorbidity index in predicting deaths in COVID-19 patients. Russian Journal of Cardiology. [Rossiyskiy kardiologicheskiy zhurnal].2022;27(3):4711 (in Russian). DOI: 10.15829/1560-4071-2022-4711][Palaiodimos L., Kokkinidis D.G., Li W., Karamanis D., Ognibene J., Arora S. et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. DOI: 10.1016/j.metabol.2020.154262][Mahmoud M., Carmisciano L., Tagliafico L., Muzyka M., Rosa G., Signori A. et al. Patterns of comorbidity and in-hospital mortality in older patients with COVID-19 infection. Front Med (Lausanne). 2021;8:726837. DOI: 10.3389/fmed.2021.726837][Gu T., Chu Q., Yu Z., Fa B., Li A., Xu L. et al. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study. BMJ Open. 2020;10(9):e038976. DOI: 10.1136/bmjopen-2020-038976][Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia — a systematic review, meta-analysis, and meta-regression. Diabetes MetabSyndr. 2020;14(4):395−403. DOI: 10.1016/j.dsx.2020.04.018]